UK’s Vaccine Taskforce

news

Funding boost for CPI’s RNA vaccine innovation centre

10 October 2022 | By Catherine Eckford (European Pharmaceutical Review)

The UK Government’s Vaccine Taskforce (VTF) has funded CPI’s innovative training academy and manufacturing facility to further the development of novel RNA therapies and vaccines.

news

Moderna announces UK mRNA Innovation and Technology Centre

23 June 2022 | By Sarah Wills (European Pharmaceutical Review)

Moderna to establish a UK mRNA Innovation and Technology Centre to produce mRNA vaccines for COVID-19, influenza, respiratory syncytial virus (RSV) and more.

article

Onshoring and global health – has the pandemic sent globalisation into reverse?

14 June 2022 | By Karen Winterhalter (Onyx Health)

The pandemic has been a game-changer for the pharmaceutical industry, sending the seemingly inexorable globalisation trends into reverse, with Big Pharma increasingly seeking more domestic supply chain options. Here, Karen Winterhalter of Onyx Health shares her expert insights on the impact of this emerging trend on the industry.

article

Vaccine innovation in the UK: SMEs and national capabilities

14 December 2020 | By Dr Gabriela Juárez Martínez (KTN), Dr Marcel Kuiper (KTN)

The UK Government is supporting the development of COVID-19 vaccines, including two innovative UK vaccine candidates. In this article, we describe the history of these candidates and introduce innovative small and medium enterprises (SMEs) and national capabilities that are working to combat the current pandemic and improve the UK’s vaccine…

news

Report finds UK Vaccine Taskforce worked “decisively” in fight against COVID-19

8 December 2020 | By Victoria Rees (European Pharmaceutical Review)

An independent review has outlined the achievements of the UK's Vaccine Taskforce, finding it worked "at great pace" to bring a COVID-19 vaccine to patients.

news

UK secures total of 357 million doses of various COVID-19 vaccines

30 November 2020 | By Victoria Rees (European Pharmaceutical Review)

After purchasing an additional two million doses of Moderna's COVID-19 vaccine, the UK will now receive a total of 357 million doses of vaccines from seven developers.

news

UK government secures early access to 90 million doses of COVID-19 vaccines

20 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

The government has entered partnerships with Pfizer and Valneva to secure doses of several promising COVID-19 vaccines and secured COVID-19 neutralising antibody treatments from AstraZeneca.